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Introduction
In skeletal muscle, satellite cells have long been described as 
“reserve” or “stem” cells. They are located between the basal 
lamina and the sarcolemma of myofi  bers and are able to self-
  renew and differentiate into mature muscle (Mauro, 1961; 
  Armand et al., 1983; Zammit and Beauchamp, 2001). Satellite 
cells are the most effi  cient cell type in skeletal muscle repair 
  after acute injury (Schultz et al., 1985; Darr and Schultz, 1987; 
Appell et al., 1988; Grounds and Yablonka-Reuveni, 1993; 
Partridge, 2004; Sherwood et al., 2004; Collins et al., 2005). 
However, contribution of other stem-like cells to muscle regen-
eration has been reported (Shi and Garry, 2006). One of these 
additional cell populations is the so-called side population (SP), 
which has been isolated from skeletal muscle using the FACS 
based on its greater ability to effl  ux the fl  uorescent dye Hoechst 
33342, when compared with the main population (MP; Gussoni 
et al., 1999; Jackson et al., 1999; Asakura et al., 2002; Montanaro 
et al., 2004). In vivo, mouse muscle SP cells can fuse to dystro-
phic myofi  bers after systemic delivery (Gussoni et al., 1999) 
and can give rise to Myf5-positive myogenic cells after intra-
muscular injection in acutely injured muscle (Asakura et al., 
2002). In vitro, muscle SP cells can adapt myogenic specifi  ca-
tion after coculture with C2C12 (Asakura et al., 2002) or are 
able to express the myogenic marker Pax7 after intravenous in-
jections into mdx5cv mice (Bachrach et al., 2004). Despite stud-
ies supporting the ability of SP cells to give rise to differentiated 
progeny in vitro and in vivo, the molecular pathways that defi  ne 
their phenotype remain unclear. We hypothesized that the spe-
cifi  c molecular networks responsible for the phenotype of SP 
cells could be identifi  ed by global gene expression analysis.
During embryonic development, a morphogen gradient of 
bone morphogenetic protein 4 (BMP4) and its antagonists plays 
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keletal muscle side population (SP) cells are thought 
to be “stem”-like cells. Despite reports conﬁ  rming 
the ability of muscle SP cells to give rise to differenti-
ated progeny in vitro and in vivo, the molecular mecha-
nisms deﬁ   ning their phenotype remain unclear. In this 
study, gene expression analyses of human fetal skeletal 
muscle demonstrate that bone morphogenetic protein 4 
(BMP4) is highly expressed in SP cells but not in main pop-
ulation (MP) mononuclear muscle-derived cells. Functional 
studies revealed that BMP4 speciﬁ  cally induces prolifera-
tion of BMP receptor 1a–positive MP cells but has no effect 
on SP cells, which are BMPR1a-negative. In contrast, the 
BMP4 antagonist Gremlin, speciﬁ  cally up-regulated in MP 
cells, counteracts the stimulatory effects of BMP4 and in-
hibits proliferation of BMPR1a-positive muscle cells. In vivo, 
BMP4-positive cells can be found in the proximity of 
  BMPR1a-positive cells in the interstitial spaces between 
myoﬁ  bers. Gremlin is expressed by mature myoﬁ  bers and 
interstitial cells, which are separate from BMP4-expressing 
cells. Together, these studies propose that BMP4 and 
Gremlin, which are highly expressed by human fetal skel-
etal muscle SP and MP cells, respectively, are regulators of 
myogenic progenitor proliferation.
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important roles in mesoderm induction, establishment of dorso-
ventral polarity, ectodermal differentiation, somite formation, 
and myogenesis induction (Hogan et al., 1994; Sasai and De 
Robertis, 1997; Dale and Jones, 1999; Giudice, 2001; Wang and 
Ferguson, 2005). In the paraxial mesoderm, local variation of 
BMP4 concentrations created by interaction between BMP4 
and its antagonists are known to differentially affect the induc-
tion of Pax3 and MyoD (Reshef et al., 1998). In developing so-
mites, BMP4 is expressed by ventral cells that give rise to the 
sclerotome, whereas BMP4 antagonists, such as Noggin, Chor-
din, Gremlin, and Follistatin are expressed in the dorsal part, 
which gives rise to the dermomyotome. A depletion of the BMP 
antagonists Noggin, Chordin, and Follistatin leads to a cata-
strophic loss of dorsal structures in Xenopus laevis (Khokha 
et al., 2005).
In the present study, microarray analysis revealed that 
BMP4, a known repressor of myogenic differentiation (Dahlqvist 
et al., 2003; Liu and Harland, 2003), is highly expressed in mus-
cle SP cells, whereas its antagonist, Gremlin (Hsu et al., 1998; 
Merino et al., 1999; Zuniga et al., 1999; Topol et al., 2000), is 
up-regulated in MP cells. Functional studies demonstrate that 
BMP4 expressed by muscle SP cells induces proliferation of 
BMP receptor 1a (BMPR1a)–positive MP cells, and this effect 
can be reversed by Gremlin. Detection of BMP4
+ and  BMPR1a
+ 
cells by immunohistochemistry in human fetal skeletal muscle 
revealed that BMP4
+ cells are located near BMPR1a
+ cells in 
the interstitial spaces, supporting the hypothesis that interac-
tions between these cells occur in vivo. Gremlin is expressed by 
mature myofi  bers and interstitial muscle cells, which are sepa-
rate from BMP4-expressing cells. Our results propose a func-
tional role for BMP4 and Gremlin, which are expressed by 
muscle SP and MP cells, respectively, as regulators of prolifera-
tion and differentiation of myogenic progenitors in human fetal 
skeletal muscle.
Results
SP cells are present in human 
skeletal muscle
SP cells have been isolated from multiple tissues (Goodell et al., 
1996, 1997), including murine skeletal muscle (Gussoni et al., 
1999; Jackson et al., 1999; Asakura et al., 2002; Montanaro 
et al., 2004). To identify SP cells in human skeletal muscle, dis-
sociated mononuclear cells from discarded muscle samples of 
individuals aged 14 gestational weeks to 63 yr were stained 
with the vital DNA dye Hoechst 33342. The dye concentration 
used for each sample was individually optimized because of ob-
served interindividual variability in sensitivity to Hoechst 33342 
dye (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200511036/DC1). After the initial optimization, indepen-
dent SP cell isolations from the same individual demonstrated 
minimal variability (Fig. S1, C–F). For fetal samples, the opti-
mal Hoechst dye concentration ranged from 3–9 μg/ml, whereas 
for adults it ranged from 7.5 to 12.5 μg/ml (Fig. S1, G and H). 
A control sample stained in the presence of reserpine allowed 
defi  nition of the appropriate SP gate. Because fetal samples 
contained the highest proportion of muscle SP cells (Fig. S1), 
all subsequent studies were performed on human fetal muscle 
SP cells.
To identify muscle SP-specifi  c cell surface markers, the 
expression of two antigens present on stem cells from other 
  tissues, CD34 (Krause et al., 1996; Asakura et al., 2002) and 
Figure 1.  Expression of cell surface antigens 
in human fetal skeletal mononuclear cells. 
(A–C) Flow cytometry analysis of 18-wk human 
fetal skeletal muscle cells. Cells were costained 
with 3 μg/ml Hoechst 33342, anti–CD34-FITC, 
anti–CD133-PE, and PI. (A) Cells stained with 
Hoechst 33342. 7.49% of the cells are de-
tected in the SP gate and 62.9% in the MP 
gate. (B) CD34-positive cells stained with 
Hoechst 33342. 3.66% of the cells are 
  detected in the SP gate and 67.2% in the MP. 
(C) CD133-positive cells stained with Hoechst 
33342. 0.56% of the cells are detected in 
the SP gate and 53.3% in the MP gate. 
(D–I)   Expression of ABCG2 (D) 3T3 cells trans-
fected with a mock vector. 99.6% of the cells 
are ABCG2-negative. (E) 3T3 cells transfected 
with human ABCG2. 60.7% of the cells are 
ABCG2-positive. (F–I) Three-color ﬂ  ow cytome-
try (Hoechst 33342, PI, and ABCG2-PE) stain-
ing proﬁ  les of 18-wk-old human fetal skeletal 
muscle. Cells were costained with 3 μg/ml 
Hoechst 33342, anti–ABCG2-FITC, and PI. 
(F) 2% of human fetal skeletal myoblasts ex-
press ABCG2. (G–H) Hoechst/PI proﬁ  les of all 
the cells stained in the presence (G) or absence 
(H) of reserpine. 2.25% of cells were detected 
as SP. Hoechst/PI proﬁ  le  of  ABCG2-positive 
cells (I) showed only one ABCG2-positive cell 
detected in the SP gate.REGULATION OF MYOGENIC PROLIFERATION BY BMP4 AND GREMLIN • FRANK ET AL. 101
CD133 (Miraglia et al., 1997; Yin et al., 1997), was analyzed. 
As shown in Fig. 1 (B and C), only 3.6% of CD34-positive cells 
and 0.56% CD133-positive cells were detected within the SP 
gate. The high dye effl  ux ability of SP cells has been previously 
attributed to the function of the ABCG2 transporter, which is 
expressed in multiple tissues, including skeletal muscle (Zhou 
et al., 2001; Martin et al., 2004; Meeson et al., 2004). In our 
  experiments, the ABCG2 transporter was detected in 2% of the 
cells in human fetal muscle (Fig. 1 F), with 76% of these cells 
present within the MP gate and only 0.25% in the muscle SP 
gate (Fig. 1 I). In control samples of mouse 3T3 cells trans-
fected with either a mock vector (Fig. 1 D) or with a vector en-
coding the human ABCG2 cDNA (Fig. 1 E), 0.37 and 60.7% of 
ABCG2-positive cells were detected, respectively. Thus, our 
studies indicate that human fetal skeletal muscle–derived SP 
cells are largely ABCG2-negative.
Previous studies reported that a variable percentage of 
murine skeletal muscle SP cells are of hematopoietic origin and 
express the pan-hematopoietic marker CD45 (McKinney-Freeman 
et al., 2002). We found that only 0.44% of human fetal skeletal 
muscle SP cells expressed CD45, suggesting that >99% of 
these cells are not of hematopoietic origin (Fig. S2, available at 
http://www.jcb.org/cgi/content/full/jcb.200511036/DC1).
Differential expression of BMP4 
and Gremlin in human skeletal muscle 
SP and MP cells
To characterize the repertoire of expressed genes and identify 
a developmental hierarchy among mononuclear cells within 
human muscle, microarray analyses were performed on 
sorted, noncultured human fetal skeletal muscle SP (n = 10) 
and MP (n = 9) cells. A detailed description of the samples 
used in the microarray studies is provided in Table S1 (avail-
able at http://www.jcb.org/cgi/content/full/jcb.200511036/
DC1). The percentage of SP cells in fetal muscle samples 
  derived from 15 different individuals ranged between 0 
and 6.57%, with no signifi  cant correlation to gestational age 
or gender.
A geometric fold change analysis of the microarray data 
(Kho et al., 2004) identifi  ed 222 unique genes/ESTs as differen-
tially regulated between human fetal skeletal muscle SP and 
MP cells (Table S2, available at http://www.jcb.org/cgi/content/
full/jcb.200511036/DC1). Of these genes, 162 known genes 
and 4 ESTs were signifi  cantly overexpressed in SP cells com-
pared with MP cells and were called SP genes, whereas 60 
genes were signifi  cantly underexpressed in the SP population 
and were called MP genes (Table S2). Gene ontology analysis 
of the differentially expressed genes using DAVID (http://niaid.
abcc.ncifcrf.gov/) indicated that SP cells express high levels of 
transcriptional repressors and negative cell-cycle regulators, 
whereas MP cells are enriched for genes involved in metabo-
lism, DNA replication, and cell surface membrane proteins 
(Table I).
Two members of TGFβ signaling pathway, BMP4 
and ID4, were found among the transcriptional repressors up-
regulated in human muscle SP cells. Intriguingly, muscle MP 
cells expressed signifi  cantly higher levels of Gremlin, a known 
antagonist of BMP4 signaling (Hsu et al., 1998; Merino et al., 
1999; Zuniga et al., 1999). The presence of high levels of 
BMP4 in SP cells and its inhibitor, Gremlin, in MP cells led to 
the hypothesis that these secreted factors could create antago-
nistic effects in the cellular environment, regulating the prolif-
eration and differentiation of mononuclear cells in human fetal 
skeletal muscle.
To test this hypothesis, we fi  rst confi  rmed the differential 
expression of BMP4 (overexpressed in SP cells) and Gremlin 
(overexpressed in MP cells) by quantitative real-time RT-PCR 
using total RNA extracted from SP and MP cells (Fig. 2 A 
and Table S3, available at http://www.jcb.org/cgi/content/full/
jcb.200511036/DC1). The results confi  rmed that SP cells ex-
press eightfold higher levels of BMP4 compared with MP cells. 
Expression of Gremlin mRNA was twofold higher in MP cells 
compared with SP cells (Fig. 2 A), whereas other known BMP4 
antagonists such as Chordin, Noggin, and Follistatin were not 
up-regulated in MP compared with SP cells at the mRNA level 
(not depicted).
Table I. Genes differentially expressed by human fetal skeletal muscle SP/MP cells
Functional category Genes up-regulated in SP Genes up-regulated in MP
Transcription CCR5, RLF, ZNF44, SIRT1, ZNF297B, TLE4, HBP1, HBXAP, DDIT3, 
MYST4, MECP2, NFATC1, NSBP1, EGR3, ZHX2, NFIB, ELF2, NFX1, 
HEY2, BLZF1, ZNF667, TBX19, SIRT4, ZNF304, FLJ11011, SIX1, 
ZNF230, JARID1A, MBD2, ZNF222, MLL, ZNF451, NR3C2, CIR, 
ARID4A, TMF1, CAMTA1, PER1, ZNF20, NR4A2, ZNF211, MAF, 
MLLT3, TNRC9
LMO4, MCM4, POLR3K, PARP1, TFDP1
Development SIRT1, CDC2L5, MYLIP, MPZ, EGR3, DGCR2, HEY2, BLZF1, TBX19, 
LECT1, SIRT4, WDR33, SIX1, RAI2, MLL, AVIL, GAS2, CCNA1, 
BMP4, IGFBP2, EDN3, CALC
GREM1, TPM1, DIRAS3, NRP1, LMO4, 
TPM4, ACTA2, SRI
Cell cycle CDKN1B, RIOK3, PLK2, CDC2L5, BCAR3, DDIT3, RAD52, NFIB, 
ABCF2, PPM1D, MLL, GAS2, CCNA1, RBBP6
DIRAS3, RRM2, RFC4, MCM4, TFDP1, 
HUS1, MCTS1, PRIM1
Biogenesis SIRT1, MYST4, BLZF1, SIRT4, H2AFJ, AVIL, ARID4A, GAS2, 
HIST1H2AE, IGFBP2, PEX1
RTCD1
Membrane proteins CCR5, MYLIP, MPZ, PCNX, SLC39A9, CNR1, DGCR2, AQP8, 
KCNAB1, POMT1, LECT1, SYT17, SCN3B, SEL1L, ABCF2, LGALS4, 
PLA2G4C, ITGAM, PEX1, CALCR
CD47, PLAUR, NRP1, COQ2, CD59, 
SSR1, ENTPD6, ICMT, DSCR2, MSN, 
TSPAN6, PIGF, ALG8, ATP5G3
Bold type indicates genes that were further investigated for function in the current study.JCB • VOLUME 175 • NUMBER 1 • 2006  102 
Next, BMP4 and Gremlin protein expression was assessed 
by immunohistochemistry on cytospins of SP and MP cells 
(Fig. 2, B and C). All images were acquired at the same expo-
sure time to enable a quantitative analysis of protein expression 
levels. This analysis demonstrated that SP cells expressed sig-
nifi  cantly higher levels of BMP4 protein than MP cells, with 
the mean pixel intensity per unit area for SP cells measured at 
506 ± 30 versus 113 ± 8 pixels/μm
2 for MP cells (mean ± 
SEM; P < 0.0001; Fig. 2 C). Gremlin was signifi  cantly more 
abundant in MP cells (455 ± 22 pixels/μm
2) compared with 
SP cells (261 ± 17 pixels/μm
2 [mean ± SEM]; P < 0.0001; 
Fig. 2 C), confi  rming the results obtained by quantitative 
real-time RT-PCR.
Effects of BMP4 and Gremlin on human 
fetal SP and MP cells
Because both RNA and protein studies demonstrated that hu-
man fetal skeletal muscle SP cells express high levels of BMP4, 
whereas MP cells express high levels of Gremlin, it was impor-
tant to investigate the functional effects of these factors on puri-
fi  ed human muscle SP and MP cells. Both BMP4 and Gremlin 
are secreted morphogens and can act in the immediate cellular 
environment as regulators of cellular proliferation or differentiation. 
To study these effects, purifi  ed human fetal muscle SP and MP 
cells were cultured for 14 d under the following four conditions: 
(1) control (no factors), (2) in the presence of BMP4, (3) in the 
presence of BMP4 and Gremlin, and (4) in the presence of 
Gremlin (Fig. 3). The factors were added at the beginning of the 
culture and exchanged every 48 h. BMP4 was added at 25 ng/ml 
according to the previously reported data (Dahlqvist et al., 
2003), and Gremlin was added at 2 μg/ml based on ED50 inhibi-
tory concentration reported by the manufacturer (R&D  Systems). 
Although MP cells differentiated and gave rise to myotubes, SP 
cells maintained their undifferentiated phenotype under all four 
conditions, indicating that BMP4 and/or Gremlin do not induce 
differentiation of SP cells (Fig. 3 A). The degree of myogenic 
differentiation of MP cells was measured by assessing the per-
centage of myogenin-positive cells (Fig. 3 B). When assessed 
by expression of myogenin at day 7 of culture in proliferation 
medium, control MP cultures had 9.07 ± 2.92% (mean ± SD) 
of myogenin-positive cells (Fig. 3 B a), whereas in the presence 
of BMP4, the percentage of myogenin-positive nuclei decreased 
to 0.1 ± 0.31% (mean ± SD; P < 0.001; Fig.  3 B b). Addition 
of Gremlin to BMP4 reversed expression of myogenin in 
14 ± 2.93% (mean ± SD) of cells (P < 0.001; Fig. 3 B c). 
  Addition of Gremlin alone did not show a signifi  cant difference 
with   control cultures, as 13.91 ± 3.55% (mean ± SD) of cells 
were myogenin-positive (Fig. 3 B d). Therefore, BMP4 had a 
Figure 2.  Expression of BMP4 and Gremlin in human fetal skeletal muscle SP and MP cells. (A) Quantitative real-time PCR of BMP4 and Gremlin mRNA 
  expression in SP (green) and MP (blue) cells. mRNA expression was measured as Ct values. Ct values for each gene were normalized to the respective 
  values for GAPDH. (B) Expression of BMP4 (top) and Gremlin (bottom) proteins in SP and MP cells. BMP4- and Gremlin-positive cells are stained in green 
(Alexa Fluor 488), and nuclei are stained in blue (DAPI). Three representative ﬁ  elds are shown for each population. (C) Quantitative immunoﬂ  uorescence 
of BMP4 (top) and Gremlin (bottom) protein expression in SP and MP cells, measured as mean pixel intensity per unit area. For BMP4, the mean pixel inten-
sity per unit area for SP cells (n = 96) is 506 ± 30, versus 113 ± 8 pixels/μm
2 for MP cells (n = 111; mean ± SEM). Gremlin expression is signiﬁ  -
cantly higher in human MP cells (n = 113; 455 ± 22 pixels/μm
2 [mean ± SEM]) than in human SP cells (n = 87; 261 ± 17 pixels/μm
2 [mean ± SEM]). 
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strong inhibitory effect on the differentiation of MP cells, 
whereas addition of Gremlin led to a complete loss of this 
 inhibitory  effect.
The effect of BMP4 and Gremlin on proliferation of SP 
and MP cells was studied by [3H]thymidine incorporation assay 
(Fig. 3 C). In cultured SP cells, exposure to Gremlin had a sig-
nifi  cant inhibitory effect on their proliferation (Fig. 3 C, left) 
compared with untreated control SP cell cultures (100 ± 62 vs. 
300 ± 103 [mean ± SD] cpm; P < 0.05), and this effect was re-
versed by the addition of BMP4. BMP4 alone, however, had no 
effect on proliferation of SP cells compared with untreated con-
trol cultures (252 ± 79 vs. 300 ± 10 [mean ± SD] cpm; NS). 
In contrast, addition of BMP4 to MP cultures (Fig. 3 C, right) 
resulted in a signifi  cant increase in their proliferation compared 
with untreated controls (5,174 ± 340 vs. 2,875 ± 1,088 [mean 
± SD] cpm; P < 0.05). This effect was reversed by the addition 
of Gremlin (4,336 ± 46 vs. 5,174 ± 340 mean ± SD] cpm; 
P < 0.05), and Gremlin alone inhibited proliferation of MP 
cells compared with the untreated control (1,579 ± 178 vs. 
2,875 ± 1,088 [mean ± SD] cpm; P < 0.05).
These results demonstrate that addition of BMP4 inhibits 
differentiation and induces proliferation of MP cells but has no 
effect on SP cells, and that addition of Gremlin can reverse 
these effects. Gremlin appears to inhibit proliferation of SP and 
MP cells, whereas it has no effect on their differentiation.
BMP4 induces proliferation of BMPR1a
+ 
cells in human skeletal muscle
To identify the population within muscle MP cells responsive 
to BMP4-induced proliferation, the expression of the BMP4-
specifi  c receptor BMPR1a (Massague et al., 1994; Wrana et al., 
1994a) was studied by fl  ow cytometry (Fig. 4). 4–11% of hu-
man muscle cells expressed BMPR1a (Fig. 4 A 3; n = 5), with 
>98% of BMPR1a
+ cells located outside the SP gate (Fig. 4 A 4). 
To study the molecular mechanism of BMP4-induced prolifera-
tion, BMPR1a
+ and BMPR1a
− cells were cultured in growth 
medium alone or in the presence of BMP4, and [3H]thymidine 
incorporation assay was performed on culture day 4 (Fig. 4 B). 
Results demonstrated that addition of BMP4 to BMPR1a
+ cul-
tures resulted in a signifi  cant increase in their proliferation com-
pared with untreated controls (4,620 ± 63 vs. 3,672 ± 124 
[mean ± SD] cpm; P < 0.05). Addition of BMP4 to BMPR1a
− 
cells had no effect on their proliferation compared with un-
treated cells. Untreated BMPR1a
+ cells demonstrated signifi  -
cantly higher proliferation than BMPR1a
− cells (3,672 ± 124 
vs. 2,553 ± 161 [mean ± SD] cpm; P < 0.05). These results 
Figure 3.  Effects of BMP4 and Gremlin on the differentiation and proliferation of human SP and MP cells. (A) Brightﬁ  eld photographs of cultured SP and 
MP cells. Under all conditions, muscle SP cells were nonadherent and morphologically round throughout the culture period, whereas MP cells differentiated 
into myotubes. Arrows point to mononuclear cells (SP and MP) and myotubes (MP, day 14). (B) Effects of BMP4 and Gremlin on human fetal muscle MP 
cell differentiation. Myogenic differentiation was visualized by immunostaining with anti–myogenin-FITC (green). (a) MP cells cultured under normal differ-
entiation conditions without addition of factors. (b) MP cells cultured in the presence of 25 ng/ml BMP4. (c) MP cells cultured in the presence of 25 ng/ml 
BMP4 and 2 μg/ml Gremlin. (d) MP cells cultured in the presence of 2 μg/ml Gremlin. Nuclei are stained in blue with DAPI. (C) [3H]thymidine incorpora-
tion by SP cells (left) and MP cells (right) cultured as described above, performed at day 7 of culture. Addition of BMP4 to MP cells resulted in a signiﬁ  cant 
increase of [3H]thymidine incorporation compared with nontreated controls, whereas it had no effect on proliferation of SP cells. Addition of Gremlin to 
BMP4-treated MP cells signiﬁ  cantly decreased their proliferation rate compared with MP cells treated with BMP4 alone. Gremlin alone inhibited prolifera-
tion of MP and SP cells compared with untreated control cultures. Error bars indicate SD. *, P < 0.05. Bars, 0.2 mm.JCB • VOLUME 175 • NUMBER 1 • 2006  104 
demonstrate that BMP4 induces proliferation of BMPR1a
+ 
cells, whereas it has no effect on BMPR1a
− cells, suggesting that 
the proliferation induced by BMP4 is mediated via BMPR1a. 
Further, BMPR1a
+ cells have a higher intrinsic proliferative 
  capacity than BMPR1a
− cells.
The activation of myogenic cells is a highly regulated pro-
cess that includes down-regulation of the satellite cell–specifi  c 
marker Pax7 (Zammit et al., 2004; Kuang et al., 2006) and the 
up-regulation of the myogenic-specifi  c factors Myf5 and MyoD 
(Rudnicki et al., 1993; Weintraub, 1993; Rudnicki and Jaenisch, 
1995; Molkentin and Olson, 1996). Muscle cells obtained from 
Myf5−/− mice show severe proliferation defi  ciency and undergo 
premature differentiation (Montarras et al., 2000). Thus, Myf5, 
which is normally expressed by satellite cells and activated myo-
blasts, is important for muscle cell proliferation (Sabourin et al., 
1999; Yablonka-Reuveni et al., 1999; Cornelison et al., 2000). 
Figure 4.  Effect of BMP4 stimulation on 
  BMPR1a-expressing cells. (A) Expression of 
BMPR1a in human fetal skeletal myoblasts. 
Three-color ﬂ   ow cytometry (Hoechst 33342, 
PI, and BMPR1a-FITC) staining proﬁ  les of an 
18-wk gestation sample. Cells were costained 
with 3 μg/ml Hoechst 33342, anti–BMPR1a-
FITC, and PI. (1 and 2) Cells stained with 
Hoechst 33342 in the presence (1) or absence 
(2) of reserpine. 1.96% of the cells are de-
tected in the SP gate. (3) 6.79% of cells are 
BMPR1a
+. (4) Approximately 99% of BM-
PR1a
+ cells are located outside of the SP gate. 
(B) [3H]thymidine incorporation by BMPR1a
+ 
and BMPR1a
− cells cultured with and without 
BMP4 for 4 d. Addition of BMP4 to BMPR1a
+ 
cultures resulted in a signiﬁ   cant increase of 
[3H]thymidine incorporation compared with 
nontreated controls. BMP4 had no effect on 
the proliferation of BMPR1a
− cells. *, P < 0.05. 
  Error bars indicate SD. (C) Expression of Myf5, 
MyoD, and Pax7 mRNA in freshly isolated 
BMPR1a
+ and BMPR1a
− cells. mRNA expression 
levels were normalized to GAPDH for each 
condition. Bars represent on a logarithmic 
scale the level of expression of each myogenic 
factor in BMPR1a
+ and BMPR1a
− relative to 
the expression of GAPDH, which is arbitrarily 
considered to be 1. The baseline expression of 
Myf5 is twofold higher in BMPR1a
+ cells than 
in BMPR1a
− cells, whereas MyoD and Pax7 
mRNA were expressed 1.5-fold higher in BMPR1a
− cells. (D) Expression of Pax7 and MyoD on cytospins of puriﬁ  ed human fetal skeletal muscle BMPR1a
+ 
and BMPR1a
− cells. By total cell count, 1.04% of 192 analyzed BMPR1a
+ cells and 12.9% of 743 analyzed BMPR1a
− cells expressed Pax7. None 
of 205 analyzed BMPR1a
+ cells and 7.4% of 594 analyzed BMPR1a
− cells expressed MyoD. BMPR1a
+ cells are stained in green (FITC), Pax7- and MyoD-
positive cells are stained in red (TRITC), and nuclei are stained in blue with DAPI. The arrows indicate Pax7- and MyoD-positive cells. The arrowheads in 
the insets in the top panels highlight the same Pax7- and MyoD-positive cells in the bottom panels, which are marked by arrows. Bars, 0.2 mm.
Figure 5.  Effect of SP cells on myogenic 
  differentiation. (A) Puriﬁ  ed human fetal muscle 
MP cells were cocultured with irradiated SP 
cells. Myogenic differentiation was visualized 
by immunostaining for myogenin (green) and 
MHC (green) at day 7 of culture. Control MP 
cultures had 22.9 ± 4.4% (mean ± SD) of 
  myogenin-positive cells and 22.4 ± 6.9% 
(mean ± SD) of MHC-positive cells, whereas 
MP cells cocultured with irradiated SP cells 
demonstrated no myogenin or MHC expres-
sion. (B) Effect of puriﬁ  ed muscle SP cells on 
proliferation of BMPR1a
+ (left) and BMPR1a
− 
(right) cells. BMPR1a
+ and BMPR1a
− cells 
were cultured with no treatment, cocultured 
with irradiated SP cells, cocultured with irradi-
ated SP cells and BMP4 blocking antibody, or 
cocultured with irradiated SP cells and IgG2b 
isotype control antibody. Proliferation was as-
sessed using a [3H]thymidine incorporation 
assay after 5 d of culture, and proliferation 
  indexes were established by calculating the 
  ratios of thymidine incorporation in treated 
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Expression of Myf5, MyoD, and Pax7 was assayed in BMPR1a
+ 
and BMPR1a
− cells by real- time quantitative RT-PCR (Fig. 4 C) 
and by immunofl  uorescence on cytospins (Fig. 4 D). The base-
line expression of Myf5 was twofold higher in BMPR1a
+ cells 
than in BMPR1a
− cells, whereas MyoD and Pax7 were ex-
pressed at higher level in BMPR1a
− cells (Fig. 4 C). Pax7 and 
MyoD protein expression assessed by cytospins demonstrated 
that signifi   cantly more BMPR1a
− than BMPR1a
+ cells ex-
pressed Pax7 and MyoD proteins (Fig. 4 D). By total cell count, 
1.04% of BMPR1a
+ cells (n = 192) and 12.9% of BMPR1a
− cells 
(n = 743) expressed Pax7. None of BMPR1a
+ cells (n = 205) 
and 7.4% of BMPR1a
− cells (n = 594) expressed MyoD. These 
results defi  ne BMPR1a
+ cells as a Myf5
high, MyoD
low, and Pax7
low 
cell population, and may provide an explanation for their 
  increased proliferation activity.
Effects of muscle SP cells on proliferation 
and differentiation of MP, BMPR1a
+, 
or BMPR1a
− cells
Our studies using synthetic morphogenic factors showed that 
addition of BMP4 induced proliferation and delayed differenti-
ation of muscle MP and BMPR1a
+ cells. To investigate whether 
BMP4-expressing SP cells also inhibit differentiation of MP 
cells, freshly purifi  ed SP cells were irradiated at 25Gy (Mozdziak 
et al., 1996) and cocultured with an equal number of MP cells. 
Myogenic differentiation was assessed by immunostaining 
for myogenin or myosin heavy chain (MHC) at culture day 7 
(Fig. 5 A). In control MP cultures (MP cells alone), 22.9 ± 
4.4% (mean ± SD) myogenin-positive cells and 22.4 ± 6.9% 
MHC-positive cells were detected, whereas in cocultures of 
MP cells with irradiated SP cells, no myogenin or MHC expres-
sion was observed (Fig. 5 A). These results demonstrate that 
BMP4-expressing SP cells inhibited differentiation of muscle 
MP cells.
To investigate whether SP cells exert a similar proliferative 
effect as recombinant BMP4 on BMPR1a
+ cells and whether 
this effect can be abrogated by specifi  c BMP4 blockade, 
 BMPR1a
+ and BMPR1a
− cells were cultured for 5 d under the 
following conditions: (1) no treatment, (2) cocultured with 
  irradiated SP cells, (3) cocultured with irradiated SP cells and 
2 μg/ml BMP4 blocking antibody, and (4) cocultured with 
 irradiated SP cells and 2 μg/ml isotype control antibody (Fig. 5 B). 
Proliferation was assessed using a [3H]thymidine incorporation 
assay, and proliferation indexes were established by calculating 
the ratios of thymidine incorporation in treated versus untreated 
cells. BMPR1a
+ cells cocultured with irradiated SP cells prolif-
erated signifi  cantly more than control BMPR1a
+ cells (prolifer-
ation index: 1.89 ± 0.27 [mean ± SEM]; P < 0.05). This effect 
was signifi  cantly reversed when 2 μg/ml of BMP4 blocking 
  antibody were added (proliferation index: 1.03 ± 0.05 [mean ± 
SEM]; P < 0.05). IgG2b isotype control antibody had no sig-
nifi  cant inhibitory effect on the proliferation of BMPR1a
+ cells 
cocultured with SP cells (proliferation index: 1.47 ± 0.4 [mean ± 
SEM]; NS). No signifi  cant effects were observed on prolifera-
tion of BMPR1a
− cells compared with untreated controls by 
coculture with irradiated SP cells (proliferation index: 1.22 ± 
0.28 [mean ± SEM]; NS), coculture with irradiated SP cells in 
the presence of BMP4 blocking antibody (proliferation index: 
0.843 ± 0.10 [mean ± SEM]; NS), or coculture with irradiated 
SP cells in the presence of IgG2b isotype control antibody (pro-
liferation index: 0.802 ± 0.08 [mean ± SEM]; NS). These re-
sults demonstrate that SP-induced proliferation of BMPR1a
+ 
cells is mediated primarily by BMP4 signaling, as it is abro-
gated by specifi  c BMP4 blockade.
Tissue localization of cells expressing 
BMP4, BMPR1a, or Gremlin
As BMP4 expression was found signifi  cantly elevated in the 
majority of human muscle SP cells compared with MP cells, 
immunostaining of human fetal skeletal muscle tissue sections 
obtained from six individuals was performed using an anti-
BMP4 antibody in an attempt to localize muscle SP cells in vivo. 
Dystrophin staining was performed simultaneously to detect 
the sarcolemma of myofi  bers (Fig. 6). Rare interstitial BMP4
+ 
cells were observed in muscle tissue sections (Fig. 6,  A–D). 
Figure 6.  Expression of BMP4 in rare interstitial human fetal muscle cells. 
(A–D) Arrowheads point to single BMP4-positive cells (green, FITC) located 
between dystrophin positive myoﬁ  bers (stained in red, Texas red). Nuclei 
are stained in blue (DAPI). (E and G) Clusters of interstitial BMP4-positive 
cells with corresponding hematoxylin/eosin staining (F and H) at lower 
magniﬁ  cation. Black squares in F and H are shown at higher magniﬁ  cation 
in E and G, respectively.JCB • VOLUME 175 • NUMBER 1 • 2006  106 
Small clusters of BMP4
+ cells were also found in areas distinct 
from myofi  bers (Fig. 6, E–H). In eight random microscopic 
fi  elds obtained from different samples, the frequency of BMP4
+ 
cells was estimated to be 1 for every 58 nuclei, corresponding to 
1.8% of the cells. To defi  ne the spatial relationships between 
BMP4- and BMPR1a-expressing cells, immunohistochemistry 
was performed on sequential sections of a 20-wk gestation fetal 
skeletal muscle sample (Fig. 7, A–F). BMP4
+ cells (Fig. 7, 
C and D) were found in the vicinity of BMPR1a
+ cells (Fig. 7, 
E and F) in the interstitial spaces surrounded by myofi  bers (Fig. 
7, A and B). BMP4-reactive cells are rounded in contours and 
have smaller cross-sectional diameters than BMP4
− skeletal 
muscle fi  bers. They focally rim the interstitial spaces formed 
by mature muscle fi  bers. Occasional cells within the interstitial 
spaces show variable membrane reactivity for BMPR1a, where 
they can be also found as clusters surrounded by BMP4
+ cells. 
Furthermore, staining for BMP4 and Gremlin (Fig. 7, G–H) was 
mutually exclusive. Gremlin was highly expressed in mature 
myofi  bers (Fig. 7 G) and scattered rounded cells in the intersti-
tium (Fig. 7 G, arrows), whereas staining for BMP4 was present 
only in rounded cells that are most prominent in the interstitium 
(Fig. 7 H, arrows). Double labeling for BMP4 and Gremlin 
(Fig. 7 H) confi  rmed the reciprocal staining pattern of intersti-
tial BMP4- or Gremlin-expressing cells.
Discussion
Skeletal muscle SP cells represent a primitive stem cell popula-
tion capable of myogenic differentiation in vitro and in vivo 
(Gussoni et al., 1999; Jackson et al., 1999; Asakura et al., 2002). 
Our data show that human fetal skeletal muscle SP cells express 
high levels of BMP4, whereas MP cells express high levels of 
the BMP4 antagonist Gremlin.
As a member of the TGFβ signaling family, BMP4 in-
duces a variety of cellular responses, initiated by binding to its 
specifi   c cellular receptor, BMPR1a (Massague et al., 1994;   
Wrana et al., 1994a,b). We found by fl  ow cytometry that >98% 
of BMPR1a
+ cells are located outside of the SP gate.  Our data 
demonstrate that BMP4 specifi  cally stimulates proliferation of 
BMPR1a
+ cells, whereas it has no effect on BMPR1a
− cells, 
suggesting that BMP4-induced proliferation is likely mediated 
by the BMPR1a receptor. BMP4 has been shown to inhibit trans-
cription of MyoD (Dahlqvist et al., 2003), a muscle-specifi  c 
transcription factor associated with withdrawal from the cell 
cycle and terminal differentiation. The myogenic transcription 
factor Myf5 is thought to be developmentally “upstream” of 
MyoD (Sabourin et al., 1999; Seale et al., 2000, 2004), and it is 
expressed in actively proliferating myogenic cells (Sabourin 
et al., 1999; Yablonka-Reuveni et al., 1999; Cornelison et al., 
2000). Our studies demonstrated a twofold increase in expres-
sion of Myf5 in uncultured, untreated BMPR1a
+ cells compared 
with BMPR1a
− cells, suggesting that these cells may have 
  intrinsic high proliferative potential. Coculture of irradiated, 
BMP4-secreting muscle SP cells with BMPR1a
+ cells signifi  -
cantly induced proliferation of the latter compared with control 
BMPR1a
+ cells cultured alone, and this effect was specifi  cally 
abrogated by BMP4 blockade. In contrast, BMPR1a
− cells did 
not increase proliferation when cultured in the presence of irra-
diated SP cells. These results suggest that muscle SP cells are 
able to induce proliferation of other myogenic precursors and 
that this effect is mediated via BMP4 signaling. In support of 
this hypothesis, BMP4
+ and BMPR1a
+ cells were found in vivo 
in close proximity of each other, with BMP4
+ cells surrounding 
small clusters of BMPR1a
+ cells, located in the interstitial 
spaces between myofi  bers.
From the current study, muscle MP cells express high lev-
els of the BMP4 inhibitor Gremlin (Hsu et al., 1998), which is 
known to bind BMP4, thus reducing BMP4 concentration in the 
cellular microenvironment. In vivo data indicate that Gremlin is 
highly expressed by mature myofi   bers and interstitial cells, 
which are distinct from BMP4-expressing cells. The observed 
Gremlin-induced growth inhibition of SP and MP cultures may 
play an important role in counteracting the stimulatory effects of 
BMP4 and in regulating the proliferation of BMPR1a
+ MP cells. 
Figure 7. Immunohistochemistry  of  human 
embryonic skeletal muscle, 20-wk gestation. 
A–F represent consecutive sections. Insets in 
A, C, and E correspond precisely to the high 
magniﬁ  cations  (1,000×) portrayed in B, D, 
and F, respectively. (A and B) Dystrophin stain-
ing deﬁ  nes mature muscle ﬁ  bers, represented 
in cross section. Inset denotes interstitial space 
containing dystrophin-negative nucleated cells. 
(C and D) BMP4-reactive cells are rounded in 
contours and have smaller cross-sectional di-
ameters than mature BMP4-negative skeletal 
muscle ﬁ   bers. BMP4-positive cells (arrow-
heads) focally rim interstitial spaces formed 
by  mature muscle ﬁ   bers. Black arrows (D) 
  deﬁ  ne the area of BMPR1a
+ cells shown in F. 
(E and F) Occasional cells within interstitial 
spaces show variable membrane reactivity 
for BMPR1a   (arrows), where they are found 
as clusters   surrounded by BMP4-positive cells 
(D and F). (G and H) Sequential sections of 20-wk fetal skeletal muscle stained for BMP4 and Gremlin. (G) Staining for Gremlin (brown; 400×); (H) staining 
for BMP4 (brown; 400×). Nuclei are stained violet. Note Gremlin staining in mature myoﬁ  bers (MF) and scattered rounded cells in the interstitium (IS; G, 
arrows). Staining for BMP4 is present only in rounded cells that are most prominent in the interstitium (H, arrows). Inset (1,000×) is double labeled (nuclei 
are   unstained), showing mutually exclusive staining for BMP4 (blue) and Gremlin (brown) by interstitial cells. Bars: (A–H) 0.2 mm; (H, inset) 0.02 mm.REGULATION OF MYOGENIC PROLIFERATION BY BMP4 AND GREMLIN • FRANK ET AL. 107
In addition to its function as a BMP4 antagonist, Gremlin has 
been shown to suppress tumor growth by mechanisms that are 
independent from BMP4, which involve both up-regulation of 
p21Cip1 and down-regulation of p42/44 MAPK (Chen et al., 
2002). Remarkably, in our studies, only Gremlin is differentially 
expressed between SP and MP cells, whereas other BMP4 
  antagonists, such as Chordin, Noggin, and Follistatin, are not 
up-regulated in MP cells. We therefore hypothesize that secre-
tion of BMP4 by SP cells and of Gremlin by MP cells generate 
antagonistic effects, infl  uencing the rate of proliferation and 
  differentiation of myogenic cells in human muscle.
High concentrations of BMP4 have been shown to induce 
osteogenic differentiation of muscle progenitor cells (Katagiri 
et al., 1994; Wright et al., 2002) and are counteracted by 
BMP4 inhibitors under normal conditions (Pereira et al., 2000). 
Overexpression of BMP4 and the inability to mount an appro-
priate antagonist (including Gremlin) response have been 
  implicated in the pathogenesis of a human disease of hetero-
topic osteogenesis, fi  brodysplasia ossifi  cans progressiva (FOP; 
Kan et al., 2004). The process of ectopic ossifi  cation in this dis-
ease is often precipitated by muscle injury, i.e., biopsy or 
trauma, when progenitor cells are being activated for muscle 
  repair. It is conceivable that the BMP4
high SP cells participate in 
muscle repair after acute injury in response to trauma, creating 
an unopposed local increase in BMP4, which may contribute 
to the formation of islands of heterotopically ossifi  ed muscle 
tissue in patients affl  icted by FOP.
The data presented here suggest that SP cells regulate 
  proliferation of more committed cells in a paracrine fashion by 
secreting BMP4, which is antagonized by its inhibitor Gremlin, 
secreted by MP cells. The functional counteraction of BMP4 
signaling by Gremlin may play a role in preventing uncontrolled 
proliferation, thus maintaining the appropriate number of pro-
genitors within the tissue. Based on our in vitro fi  ndings, we 
propose that expression and secretion of BMP4 by quiescent 
muscle SP cells (Fig. 8 A) induces proliferation of BMPR1a
+ 
Myf5
high muscle MP cells (Fig. 8 B). This proliferation is coun-
teracted by secretion of Gremlin by BMPR1a
− Myf5
low com-
mitted MP cells (Fig. 8 C). The demonstrated tissue localization 
of BMP4
+ and BMPR1a
+ cells in close proximity of each other 
and the mutually exclusive staining pattern of BMP4 and Grem-
lin suggest that these interactions also occur in vivo. This study 
provides additional insights into the complex functional hierar-
chy among the mononuclear cells in skeletal muscle and leads 
to important correlations with other stem cell niches, such as the 
skin, bone marrow, and intestine, where stem cells use BMP4 
signaling to regulate the proliferation of their daughter cells, 
which in turn differentiate into committed cells and tissues 
  (Kobielak et al., 2003; Zhang et al., 2003; Haramis et al., 2004).
Materials and methods
Tissue preparation, Hoechst 33342 staining, and ﬂ  ow cytometry analyses
Mononuclear cells were isolated from discarded human fetal skeletal mus-
cle of gestational age 14–18 wk (Advanced Bioscience Resources). Tissues 
were collected in sterile HBSS with 1% glucose and 1% penicillin/strepto-
mycin, ﬁ   nely minced using sterile scalpels, and digested using dispase 
(0.6 U/ml) and collagenase (0.5 mg/ml; Worthington) diluted in PBS. 
  Digested samples were ﬁ  ltered through a 40-μm cell strainer before staining 
and analysis (Pavlath and Gussoni, 2005).
Mononuclear cells were centrifuged at 365 g for 10 min and resus-
pended at a concentration of 10
6 cells/ml in prewarmed (37°C) PBS/0.5% 
BSA. Hoechst 33342 dye (Sigma-Aldrich) was added at a ﬁ  nal concentra-
tion of 3–9 μg/ml for fetal samples and 7.5–12.5 μg/ml for adult samples. 
In parallel, as a negative control for SP cell gating, 5 × 10
5 muscle cells 
were stained with Hoechst 33342 in the presence of 5 μM reserpine 
(Sigma-Aldrich). Cells were incubated for 60 min at 37°C, protected from 
light in a waterbath, and washed by adding 3.5–5 volumes of ice-cold 
PBS/0.5% BSA.
For labeling with speciﬁ  c antibodies, after Hoechst 33342 staining, 
samples were pelleted, resuspended at a concentration of 10
7–10
8 cells/
ml, and incubated with the following antibodies: anti-human CD34-FITC 
(BD Biosciences), anti-human CD133-PE (Miltenyi Biotec), anti-CD45-PE 
(Miltenyi Biotec), rat IgG-PE (BD Biosciences), anti-ABCG2 (Stem Cell Tech-
nologies), or anti-BMPR1a (Santa Cruz Biotechnology, Inc.). Control sam-
ples of 3T3 cells transfected with either mock- or human ABCG2–encoding 
vectors were provided by B. Sorrentino (St. Jude Children’s Research Hos-
pital, Memphis, TN). Cells were incubated for 15 min on ice, washed, and 
resuspended in ice-cold PBS/0.5% BSA containing 2 μg/ml propidium io-
dide (PI). For detection of ABCG2 and BMPR1a
+ cells, incubation with 
FITC-conjugated secondary anti-mouse (BD Biosciences) or anti-rabbit 
(Jackson ImmunoResearch Laboratories) antibody was performed for 
10 min on ice. Subsequently, the cells were washed with cold PBS/0.5% 
BSA and resuspended in ice-cold 1× PBS/0.5% BSA containing 2 μg/ml PI. 
Flow cytometric analyses and cell sorting were performed on a dual-  laser 
FACSVantage SE ﬂ   ow cytometer (Becton Dickinson) equipped with two 
  lasers: one with 200 MW power (488 nm) and one with 150 MW power 
(UV). Both the Hoechst and PI dyes were excited at 350 nm, and their 
  ﬂ  uorescence was measured at 400 and 600 long pass, respectively, with 
a 550 short pass dichroic mirror. For each sample analyzed, 20,000 
total cell counts were acquired using CellQuest software version 3.3 
(Becton Dickinson).
Sample preparation for microarray analysis
Total RNA was extracted from sorted human fetal muscle SP and MP cells 
using the RNeasy kit (QIAGEN). Total RNA (100 ng) from 10 SP and 9 MP 
samples were subjected to two rounds of linear ampliﬁ   cation using a 
  MessageAmp kit (Ambion). After ampliﬁ  cation, 20 μg of fragmented, 
  biotin-labeled cRNA was prepared and hybridized onto the Affymetrix 
  human HG-U133A GeneChip (as per the manufacturer’s instructions). 
  Microarrays were optically scanned, and images were processed using 
the Affymetrix GeneChip MAS5.0 analysis software, which were then 
  summarized in a CHP ﬁ   le. Each surveyed gene transcript was given a 
mean ﬂ  uorescence intensity value (signal) indicating the amount of the tran-
script detected and a call (present, absent, or marginal) indicating the 
  robustness of its detection.
Microarray data analysis
Each Affymetrix HG-U133A microarray contains 22,283 individual probes 
for gene/RNA transcripts. Using a geometric logarithmic fold analysis 
Figure 8.  Schematic illustration of the proposed cellular hierarchy within 
skeletal muscle. BMP4
high quiescent SP cells (A, red) induce the prolifera-
tion of BMPR1a
+ Myf5
high MP cells (B, purple) via BMP4 secretion, and 
BMPR1a
− Myf5
low Gremlin
high committed MP cells (C, blue) may inhibit the 
stimulatory effect of BMP4 by secreting Gremlin. Cells are displayed sche-
matically according to their respective positions in the Hoechst/PI proﬁ  le.JCB • VOLUME 175 • NUMBER 1 • 2006  108 
(Haslett et al., 2003; Kho et al., 2004), 244 probes had a statistically 
  signiﬁ  cant differential reading between the SP (n = 10) and MP (n = 9) 
groups. Two criteria had to be satisﬁ  ed for signiﬁ  cant differential expres-
sion: (1) AbsoluteValue(AvgLF) − StdLF > 0.4 × Local_Fold_Noise and (2) 
AbsoluteValue(AvgLF)  > max(Local_Fold_Noise, Global_Fold_Noise). 
AvgLF and StdLF denote the mean and standard deviation of the logarith-
mic fold change of a probe in the SP relative to the MP group, respectively. 
For each probe, Local_Fold_Noise is the largest logarithmic fold change 
for the probe within the MP or the SP groups. Global_Fold_Noise is the 
mean of Local_Fold_Noise over all 22,283 probes. The false discovery 
rate (FDR) for this approach was <1% after a permutation analysis with 
10,000 independent shufﬂ  ing iterations. In each iteration, the 19 sample 
labels (MP or SP) of each of the 22,283 probes were ﬁ  rst randomly shuf-
ﬂ  ed. Then, the number of probes from this shufﬂ  ed dataset that came up as 
signiﬁ  cant (i.e., false positives) using the two criteria above were counted. 
The FDR is the median of these 10,000 false positive counts over 244, the 
number of probes called signiﬁ  cantly differentially expressed in the origi-
nal unshufﬂ  ed dataset. These 244 probes (corresponding to 222 unique 
genes) were functionally annotated using the web-based Database for 
  Annotation, Visualization, and Integrated Discovery 2.0 (DAVID 2.0; 
http://niaid.abcc.ncifcrf.gov/; Dennis et al., 2003).
Real-time quantitative PCR analysis
Total RNA (100 ng) isolated from freshly sorted human fetal skeletal muscle 
SP and MP cells or from BMPR1a
+ and BMPR1a
− cells was reverse tran-
scribed using the Taqman reverse transcription kit (Applied Biosystems) 
in a 100 μl reaction volume according to the manufacturer’s protocol. 
Approximately 20 pcg of cDNA (1 μl of RT reaction product) was used for 
PCR ampliﬁ  cation. Samples were assayed using Sybergreen chemistry and 
kinetic PCR (ABI 7700 Sequence Detector; Applied Biosystems). Samples 
were ampliﬁ  ed using the Sybergreen PCR reagent kit (Applied Biosystems) 
according to the manufacturer’s protocol. Sense and antisense primers 
were used at a ﬁ  nal concentration of 300 nM. The primer sequences for 
the genes tested are listed in Table S3. The cDNA samples were ampliﬁ  ed 
under “default” conditions: 50°C for 2 min and 95°C for 10 min, followed 
by 40 cycles of ampliﬁ  cation at 94°C for 15 s and 60°C for 1 min. For 
data analysis, the cycle threshold (Ct) number was computed for each sam-
ple using the Sequence Detection Software (Applied Biosystems). The Ct 
baseline was preset at 10 standard deviations above the ﬂ  uorescence 
background, which was determined in the ﬁ  rst 3–15 cycles. All quantita-
tions were normalized to the endogenous control gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) to account for variability in the initial 
concentration and quality of the total RNA, and the efﬁ  ciency of the reverse 
transcription reaction. Differential Ct values (Ct for the gene of interest 
  minus Ct for GAPDH) were calculated for each ampliﬁ  ed gene. Logarithmic 
fold change of gene expression between samples was calculated by 
  subtracting gene-speciﬁ  c differential Ct values.
Immunohistochemistry
For cytospin preparation, human fetal skeletal muscle SP, MP, BMPR1a
+, 
and BMPR1a
− cells were puriﬁ  ed by ﬂ  ow cytometry. Cells (1,000 cells/
slide) were placed on glass slides by centrifugation in a cytospin centrifuge 
(Thermo Electron Corp.). Slides were ﬁ  xed in absolute methanol for 3 min 
at room temperature, blocked for 30 min in blocking solution (10% fetal 
bovine serum and 0.1% Triton X-100), and incubated with mouse anti-
Pax7 monoclonal antibody (diluted 1:15; Developmental Studies Hybrid-
oma Bank) or mouse anti-MyoD monoclonal antibody (diluted at 1:50; 
BD Biosciences) overnight at 4°C. Slides were washed in 1× PBS/0.1% 
Triton X-100 and incubated with goat anti–mouse or goat anti–rabbit FITC-
conjugated secondary antibody (diluted 1:100; Jackson ImmunoResearch 
Laboratories) for 1 h at room temperature. For BMP4 and Gremlin staining, 
cytospin slides were ﬁ  xed in 4% paraformaldehyde for 20 min at room 
temperature, blocked for 30 min in 10% fetal bovine serum and 0.1% 
  Triton X-100, and incubated with mouse anti-BMP4 monoclonal antibody 
(diluted 1: 20; Novocastra) or rabbit anti-Gremlin polyclonal antibody 
  (diluted 1:50; Abgent) overnight at 4°C. Slides were washed in 1× 
PBS/0.1% Triton X-100 and incubated with goat anti–mouse Alexa Fluor 
488 or goat anti–rabbit Alexa Fluor 488 secondary antibody (diluted 
1:200; Invitrogen) for 1 h at room temperature and washed in 1× 
PBS/0.1% Triton X-100. Slides were then mounted in Vectashield (Vector 
Laboratories) supplemented with 100 ng/ml DAPI to visualize nuclei. 
  Images from Pax7- and MyoD-stained BMPR1a
+ and BMPR1a
− cells were 
acquired in ﬁ  ve random microscopic ﬁ  elds for each sample using 200 and 
400 magniﬁ   cation objective on a microscope (E1000; Nikon), photo-
graphed using a camera (Orca ER; Hamamatsu), and processed using 
OpenLab software version 3.1.5 (Improvision). For quantitative analysis, 
images from BMP4- and Gremlin-stained SP and MP cells were acquired in 
10 random microscopic ﬁ  elds for each sample on an automated upright 
ﬂ   uorescent microscope (Eclipse 90I; Nikon) using 200 magniﬁ  cation 
  objective and processed using MetaMorph 7.0 software (Molecular 
  Devices). Images were photographed using a camera (Orca II; Hama-
matsu). The intensity of ﬂ  uorescence labeling between the SP and MP cells 
was compared using the mean integrated intensity per unit area, to correct 
for differences in cell size. Using MetaMorph software, a region of interest 
was drawn around each cell to be measured and the integrated intensity 
of the region was calculated. To correct for local changes in background 
intensity, the region was then moved to a background area of the ﬁ  eld of 
view close to the cell of interest and integrated intensity was recorded. The 
integrated intensity of the background was subtracted from the integrated 
intensity of the cell being measured. Integrated pixel intensity was calcu-
lated for each cell in the ﬁ  eld and then divided by the area of the cell 
to calculate mean pixel intensity per unit area. Mean pixel intensities for 
SP and MP cells were then statistically compared using the nonparametric 
Wilcoxon test.
For immunoﬂ  uorescence analysis of cultured human MP cells, cells 
seeded in 96-well plates were washed three times with PBS, ﬁ  xed in abso-
lute methanol, blocked for 30 min in 10% fetal bovine serum/0.1% Triton 
X-100 in PBS, and incubated with mouse anti-MHC monoclonal antibody 
(MF20; diluted 1:15; Developmental Studies Hybridoma Bank) or anti-
myogenin mouse monoclonal (diluted 1:50; DakoCytomation) overnight at 
4°C. Wells were washed, incubated with goat anti–mouse FITC-conjugated 
secondary antibody (diluted 1:100; Jackson ImmunoResearch Laborato-
ries), and processed as described for cytospins. Plates were visualized with 
a 200 magniﬁ  cation objective on a microscope (Eclipse TE2000-S; Nikon) 
and photographed using an Orca ER camera, and images were processed 
using OpenLab software version 3.1.5.
For immunoﬂ   uorescence studies on human fetal skeletal muscle, 
10-μm tissue sections were collected on sialanazed slides (Polysciences, Inc.), 
ﬁ  xed in absolute methanol, and blocked as described for cytospins before 
incubation with mouse anti-BMP4 (diluted 1:20; Novocastra) and anti-
  dystrophin CAP6-10 polyclonal antibody diluted at 1:500 in PBS (Byers 
et al., 1993; Gussoni et al., 1999). Slides were subsequently processed as 
described for cytospins.
For immunohistochemistry, 5-μm-thick sequentially cut muscle cryo-
sections were ﬁ  xed in −20°C acetone for 5 min. Air-dried sections were 
incubated with anti-dystrophin CAP6-10 polyclonal antibody diluted at 
1:1,000, 2.5 μg/ml anti-BMP4 mouse mAb (R&D Systems) at 4°C over-
night, or 0.01 μg/ml anti-BMPR1a rabbit polyclonal antibody (Orbigen, 
Inc.) for 1 h at room temperature or a mix of Gremlin polyclonal antibody 
(diluted 1:50; Abgent) and 2.5 μg/ml anti-BMP4 mouse mAb. As negative 
controls, 10 μg/ml mouse IgG and 2.5 μg/ml rabbit IgG were used. 
  Sections were washed with PBS 3× for 5 min and incubated with 1:200 
horseradish peroxidase–conjugated goat anti–rabbit secondary antibody 
for dystrophin and BMPR1a staining and 1:200 horseradish peroxidase–
conjugated horse anti–mouse secondary antibody or 1:200 alkaline phos-
phatase–conjugated horse anti–mouse secondary antibody for BMP4 
staining, and 1:200 biotinylated goat anti–rabbit secondary antibody for 
30 min at room temperature (Vector Laboratories) for Gremlin staining, fol-
lowed by ABC complex incubation at room temperature for 30 min. Immuno-
reactivity was detected using NovaRed substrate (Vector Laboratories). 
After washing, the sections were mounted with Vectashield mounting 
  medium. Immunohistochemistry reactivity was visualized with a 200, 400, 
and 1,000 magniﬁ  cation objective on a microscope (Eclipse 80I; Nikon) 
coupled to a Cytovision system (Applied Imaging) and photographed 
  using an Orca ER camera.
Cell culture and proliferation assays
Sorted human fetal muscle BMPR1a
+ and BMPR1a
− cells, as well as SP 
and MP cells, were seeded in 96-well plates at 3 × 10
3 cells/well in tripli-
cates and incubated in growth medium consisting of DME with 4% glu-
cose, 20% fetal bovine serum (vol/vol), 1% (vol/vol) penicillin-streptomycin 
(10,000 UI/ml–10,000 μg/ml; Invitrogen) for 4–14 d. For BMP4 and 
Gremlin stimulation, 25 ng/ml human recombinant BMP4 (R&D Systems) 
or 2 μg/ml mouse recombinant Gremlin (R&D Systems) were exchanged 
every 48 h. Control wells contained sorted SP and MP cells maintained in 
growth medium without the addition of BMP4 or Gremlin. For coculture ex-
periments, muscle SP cells were irradiated at 25 Gy and seeded together 
with MP, BMPR1a
+, or BMPR1a
− cells at 1:1 ratios. Blocking anti-BMP4 
antibody (R&D Systems) and isotype control IgG2b antibody (R&D 
Systems) were added to cocultured SP with BMPR1a
+ or BMPR1a
− cells at 
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Cell proliferation was assessed for SP/MP, BMPR1a
+, and BM-
PR1a
− cells after a culture period of 4–7 d by [3H]thymidine incorporation 
(1 μCi/well) for the last 18 h of culture (Frank et al., 2001). Cells were 
harvested using an automated cell harvester, and incorporated radioactiv-
ity was assessed by a BetaMax counter (Beckman Coulter). The results of 
proliferation assays were compared using the Kruskal-Wallis test for compar-
ing populations with unknown distributions (results are shown as p-values). 
Differences with P < 0.05 were considered statistically signiﬁ  cant.
Online supplemental materials
Fig. S1 illustrates Hoechst/PI proﬁ  les of human skeletal muscle cells ob-
tained from different individuals. Fig. S2 illustrates expression of CD45 by 
human fetal skeletal muscle SP cells. Table S1 describes SP and MP sam-
ples subjected to microarray studies. Table S2 lists 222 genes differentially 
expressed between human fetal skeletal muscle SP and MP cells. Table S3 
provides sequences for primers used in real-time PCR reactions. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200511036/DC1.
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